|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/52 | |||
| C07D 491/16 | |||
| C07D 491/12 | |||
| C07D 491/18 | |||
| C07D 498/18 | |||
| A61P 35/00 |
| (11) | Number of the document | 3325488 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16828471.9 |
| Date of filing the European patent application | 2016-07-20 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/043132 |
| Date | 2016-07-20 |
| (87) | Number | WO 2017/015367 |
| Date | 2017-01-26 |
| (30) | Number | Date | Country code |
| 201562195081 P | 2015-07-21 | US | |
| 201662302231 P | 2016-03-02 | US |
| (72) |
CUI, Jingrong Jean, US
LI, Yishan, US
ROGERS, Evan W., US
ZHAI, Dayong, US
DENG, Wei, US
HUANG, Zhongdong, US
|
| (73) |
Turning Point Therapeutics, Inc.,
10628 Science Center Drive, Ste. 225, San Diego, CA 92121,
US
|
| (54) | CHIRAL DIARYL MACROCYCLE AND USE THEREOF IN THE TREATMENT OF CANCER |
| CHIRAL DIARYL MACROCYCLE AND USE THEREOF IN THE TREATMENT OF CANCER |